{"id":11308,"date":"2022-07-01T20:31:38","date_gmt":"2022-07-02T00:31:38","guid":{"rendered":"https:\/\/www.cancerresearch.org\/event\/immunotherapy-for-prostate-cancer\/"},"modified":"2022-07-14T16:00:25","modified_gmt":"2022-07-14T20:00:25","slug":"immunotherapy-for-prostate-cancer","status":"publish","type":"cri_events","link":"https:\/\/www.cancerresearch.org\/es\/events\/immunotherapy-for-prostate-cancer","title":{"rendered":"Immunotherapy for Prostate Cancer"},"content":{"rendered":"<p style=\"text-align:center\"><iframe loading=\"lazy\" allowfullscreen=\"\" frameborder=\"0\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/M1ec_sc8oNw\" width=\"640\"><\/iframe><\/p>\n<p>On September 30, 2014, Charles G. Drake, MD, PhD, an associate professor of oncology, urology, and immunology at&nbsp; the Johns Hopkins School of Medicine, discussed current immunotherapy treatment options for patients with prostate cancer, and how close we are to making these treatments available to more patients.<\/p>\n<p>Dr. Drake also serves as co-director of the Prostate Cancer Multidisciplinary Clinic. His areas of expertise include immunotherapy and the diagnosis and treatment of cancers of the prostate, kidney, bladder, and testes. Dr. Drake graduated with a B.S. in electrical engineering and M.S. in biomedical engineering from Rutgers University. He then received a PhD in immunology from the National Jewish Center for Immunology, and in 1997 completed an MD at the University of Colorado Health Sciences Center. He conducted an internal medicine residency on the Osler Service at Johns Hopkins, and in 2002 he completed a fellowship in medical oncology, also at Johns Hopkins. He joined the Johns Hopkins faculty as an assistant professor in 2002. Dr. Drake has published extensively, has won numerous awards and honors for his research and scholarship, and holds several patent.<\/p>\n<p>This webinar is part of the Cancer Research Institute&#39;s webinar series, &quot;Cancer Immunotherapy and You,&quot; which are offered free to the public and feature&nbsp;informative updates for patients and caregivers from leaders in cancer immunotherapy, followed by a Q&amp;A. This webinar&nbsp;was generously supported by Dendreon. For more information on this webinar, or to register for upcoming webinars, please visit <a href=\"https:\/\/www.cancerresearch.org\/webinars\" target=\"_blank\" rel=\"noopener\">www.cancerresearch.org\/webinars<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Charles G. Drake of Johns Hopkins shares&nbsp;the latest research and available immune-based treatments for patients with prostate cancer.<\/p>\n","protected":false},"featured_media":1728,"template":"","events_categories":[198],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-11308","cri_events","type-cri_events","status-publish","has-post-thumbnail","hentry","events_categories-webinars"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Immunotherapy for Prostate Cancer<\/title>\n<meta name=\"description\" content=\"Dr. Charles G. Drake of Johns Hopkins shares\u00a0the latest research and available immune-based treatments for patients with prostate cancer.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-prostate-cancer\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Immunotherapy for Prostate Cancer\" \/>\n<meta property=\"og:description\" content=\"Dr. Charles G. Drake of Johns Hopkins shares\u00a0the latest research and available immune-based treatments for patients with prostate cancer.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-prostate-cancer\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-14T20:00:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/86897f65-ed36-47a7-a094-af0b2f174c72.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Immunotherapy for Prostate Cancer\" \/>\n<meta name=\"twitter:description\" content=\"Dr. Charles G. Drake of Johns Hopkins shares\u00a0the latest research and available immune-based treatments for patients with prostate cancer.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/86897f65-ed36-47a7-a094-af0b2f174c72.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-prostate-cancer\",\"url\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-prostate-cancer\",\"name\":\"Immunotherapy for Prostate Cancer\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-prostate-cancer#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-prostate-cancer#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/192b6a50-7191-440a-9039-91d0f4d120b1.jpg\",\"datePublished\":\"2022-07-02T00:31:38+00:00\",\"dateModified\":\"2022-07-14T20:00:25+00:00\",\"description\":\"Dr. Charles G. Drake of Johns Hopkins shares\u00a0the latest research and available immune-based treatments for patients with prostate cancer.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-prostate-cancer#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-prostate-cancer\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-prostate-cancer#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/192b6a50-7191-440a-9039-91d0f4d120b1.jpg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/192b6a50-7191-440a-9039-91d0f4d120b1.jpg\",\"width\":320,\"height\":208},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-prostate-cancer#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Event\",\"item\":\"https:\/\/www.cancerresearch.org\/events\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Immunotherapy for Prostate Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Immunotherapy for Prostate Cancer","description":"Dr. Charles G. Drake of Johns Hopkins shares\u00a0the latest research and available immune-based treatments for patients with prostate cancer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-prostate-cancer","og_locale":"es_ES","og_type":"article","og_title":"Immunotherapy for Prostate Cancer","og_description":"Dr. Charles G. Drake of Johns Hopkins shares\u00a0the latest research and available immune-based treatments for patients with prostate cancer.","og_url":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-prostate-cancer","og_site_name":"Cancer Research Institute","article_modified_time":"2022-07-14T20:00:25+00:00","og_image":[{"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/86897f65-ed36-47a7-a094-af0b2f174c72.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"Immunotherapy for Prostate Cancer","twitter_description":"Dr. Charles G. Drake of Johns Hopkins shares\u00a0the latest research and available immune-based treatments for patients with prostate cancer.","twitter_image":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/86897f65-ed36-47a7-a094-af0b2f174c72.jpg","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-prostate-cancer","url":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-prostate-cancer","name":"Immunotherapy for Prostate Cancer","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-prostate-cancer#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-prostate-cancer#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/192b6a50-7191-440a-9039-91d0f4d120b1.jpg","datePublished":"2022-07-02T00:31:38+00:00","dateModified":"2022-07-14T20:00:25+00:00","description":"Dr. Charles G. Drake of Johns Hopkins shares\u00a0the latest research and available immune-based treatments for patients with prostate cancer.","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-prostate-cancer#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-prostate-cancer"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-prostate-cancer#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/192b6a50-7191-440a-9039-91d0f4d120b1.jpg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/192b6a50-7191-440a-9039-91d0f4d120b1.jpg","width":320,"height":208},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-prostate-cancer#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Event","item":"https:\/\/www.cancerresearch.org\/events"},{"@type":"ListItem","position":3,"name":"Immunotherapy for Prostate Cancer"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events\/11308","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_events"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/1728"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=11308"}],"wp:term":[{"taxonomy":"events_categories","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/events_categories?post=11308"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=11308"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=11308"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=11308"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=11308"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=11308"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}